Percutaneous liver biopsy practice patterns among Canadian hepatologists

Canadian Journal of Gastroenterology

Volumn 27, Issue 11, 2013, Pages

  Aljawad, Mohammed ^a   Yoshida, Eric M ^b   Uhanova, Julia ^c   Marotta, Paul ^a   Chandok, Natasha ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Liver biopsy; Liver disease; Practice patterns

Indexed keywords

ARTICLE; CANADA; CLINICAL PRACTICE; ECHOGRAPHY; ENDOSCOPY; FEMALE; HEPATOLOGIST; HUMAN; LIVER BIOPSY; MALE; MEDICAL SPECIALIST; PATIENT PREFERENCE; PERCUTANEOUS BIOPSY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REIMBURSEMENT;

ATTITUDE OF HEALTH PERSONNEL; BIOPSY, NEEDLE; CANADA; ENDOSCOPY; FEMALE; GASTROENTEROLOGY; HEALTH CARE SURVEYS; HUMANS; LIVER DISEASES; MALE; PATIENT PREFERENCE; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION; REIMBURSEMENT MECHANISMS;

EID: 84887233565     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/429834     Document Type: Article

References (27)

1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009;49:1017-44.
2. van Leeuwen DJ, Wilson L, Crowe DR. Liver biopsy in the mid-1990s: Questions and answers. Semin Liver Dis 1995;15:340-59.
3. Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010;8:877-83.
4. West J, Card TR. Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology 2010;139:1230-7.
5. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int 2008;28:705-12.
6. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut 1999;(45 Suppl 4):IV1-IV11.
7. Caturelli E, Giacobbe A, Facciorusso D, et al. Percutaneous biopsy in diffuse liver disease: Increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol 1996;91:1318-21.
8. Manolakopoulos S, Triantos C, Bethanis S, et al. Ultrasound-guided liver biopsy in real life: Comparison of same-day prebiopsy versus real-time ultrasound approach. J Gastroenterol Hepatol 2007;22:1490-3.
9. Muir AJ, Trotter JF. A survey of current liver biopsy practice patterns. J Clin Gastroenterol 2002;35:86-8.
10. Angtuaco TL, Lal SK, Banaad-Omiotek GD, Zaidi SS, Howden CW. Current liver biopsy practices for suspected parenchymal liver diseases in the United States: The evolving role of radiologists. Am J Gastroenterol 2002;97:1468-71.
11. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-8.
12. Olsson R, Hagerstrand I, Broome U, et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995;48:933-5.
13. Poynard T, Munteanu M, Imbert-Bismut F, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;50:1344-55.
14. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57.
15. Robert M, Sofair AN, Thomas A, et al. A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C. Clin Gastroenterol Hepatol 2009;7:335-8.
16. Poynard T, Morra R, Halfon P, et al. Meta-analyses of Fibro Test diagnostic value in chronic liver disease. BMC Gastroenterol 2007;7:40.
17. Shaheen AA, Wan AF, Myers RP. Fibro Test and Fibro Scan for the prediction of hepatitis C-related fibrosis: A systematic review of diagnostic test accuracy. Am J Gastroenterol 2007;102:2589-600.
18. Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, Fibro Test and Fibro Scan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 2010;10:103.
19. Degos F, Perez P, Roche B, et al. Diagnostic accuracy of Fibro Scan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J Hepatol 2010;53:1013-21.
20. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: A metaanalysis. Gastroenterology 2008;134:960-74.
21. Boursier J, Zarski JP, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013;57:1182-91.
22. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008;135:32-40.
23. Wang QB, Zhu H, Liu HL, Zhang B. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology 2012;56:239-47.
24. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: Summary of a workshop. Hepatology 2002;36:227-42.
25. Mayoral W, Lewis JH. Percutaneous liver biopsy: What is the current approach? Results of a questionnaire survey. Dig Dis Sci 2001;46:118-27.
26. Lindor KD, Bru C, Jorgensen RA, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079-83.
27. Younossi ZM, Teran JC, Ganiats TG, Carey WD. Ultrasoundguided liver biopsy for parenchymal liver disease: An economic analysis. Dig Dis Sci 1998;43:46-50.